These data demonstrate that neutralization of IGFBP1 prevents against NASH progression in Wtap-HKO mice, and further support that increased IGFBP1 may be the primary cause for the increased lipolysis in the white adipose tissue and NASH in Wtap-HKO mice. The gene discussed is IGFBP1; the disease is metabolic dysfunction-associated steatohepatitis.